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Abstract
Background Frailty is the pre-eminent exigency of aging. Although frailty-related impairments are preventable, and
multidomain interventions appear more effective than unimodal ones, the optimal components remain uncertain.
Methods We devised multidomain interventions against physical and cognitive decline among prefrail/frail community-
dwelling ≥65-year-olds and evaluated these in complementary cluster-randomized trials of efficacy and participant empower-
ment. The Efficacy Study compared ~3-monthly telephone consultations vs. 16, 2 h sessions/year comprising communally
partaken physical and cognitive training plus nutrition and disease education; the Empowerment Study compared the standard
Efficacy Study multidomain intervention (Sessions 1–10) vs. an enhanced version redesigned to empower and motivate indi-
vidual participants. Changes from baseline in physical, functional, and cognitive performance were measured after 6 and 12
months in the Efficacy Study and after 6 months in the Empowerment Study, with post-intervention follow-up at 9 months.
Primary outcomes are as follows: Cardiovascular Health Study frailty score; gait speed; handgrip strength; and Montreal Cog-
nitive Assessment (MoCA). Secondary outcomes are as follows: instrumental activities of daily living; metabolic equivalent of
task (MET); depressed mood (Geriatric Depression Scale-5 ≥2); and malnutrition (Mini-Nutritional Assessment short-form ≤11).
Intervention effects were analyzed using a generalized linear mixed model.
Results Efficacy Study participants (n = 1082, 40 clusters) were 75.1 ± 6.3 years old, 68.7% women, and 64.7% prefrail/frail;
analytic clusters: 19 intervention (410/549 completed) vs. 21 control (375/533 completed). Empowerment Study participants
(n = 440, 14 clusters) were 75.9 ± 7.1 years old, 83.6% women, and 56.7% prefrail/frail; analytic clusters: seven intervention
(209/230 completed) vs. seven control (189/210 completed). The standard and enhanced multidomain interventions both re-
duced frailty and significantly improved aspects of physical, functional, and cognitive performance, especially among ≥75-year-
olds. Standard multidomain intervention decreased depression [odds ratio 0.56, 95% confidence interval (CI) 0.32, 0.99] and
malnutrition (odds ratio 0.45, 95% CI 0.26, 0.78) by 12 months and improved concentration at Months 6 (0.23, 95% CI 0.04,
0.42) and 12 (0.46, 95% CI 0.22, 0.70). Participant empowerment augmented activity (4.67 MET/h, 95% CI 1.64, 7.69) and gait
speed (0.06 m/s, 95% CI 0.00, 0.11) at 6 months, with sustained improvements in delayed recall (0.63, 95% CI 0.20, 1.06) and
MoCA performance (1.29, 95% CI 0.54, 2.03), and less prevalent malnutrition (odds ratio 0.39, 95% CI 0.18, 0.84), 3 months
after the intervention ceased.
Conclusions Pragmatic multidomain intervention can diminish physical frailty, malnutrition, and depression and enhance
cognitive performance among community-dwelling elders, especially ≥75-year-olds; this might supplement healthy aging pol-
icies, probably more effectively if participants are empowered.
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Introduction
Population aging is a global problem, imposing substantial
and rapidly increasing health care and socio-economic bur-
dens.1,2 Its most exigent manifestation is frailty, a distinct
geriatric phenotype prognostic of disability, loss of indepen-
dence, and earlier death, irrespective of age or morbidity
status.1,3–5 Frail individuals are less likely and slower to
recover from injury or stressful life events, steepening the
trajectory of physical, functional, and cognitive decline.1,4
The prevalence of frailty among community-dwelling
≥65-year-olds from predominantly Europid populations av-
erages approximately 10–12%, within wide bounds.6,7 Until
recently, frailty appeared relatively less common in East
Asians,7–9 but this is changing; Taiwan has the most rapidly
aging populace in the world, which is expected to transition
from aged (14% of the population ≥65 years old) in 2018 to
super-aged (20% ≥65 years old) in less than 10 years, with
profound health policy implications.2,10 For these reasons,
‘healthy aging’ to promote well-being and forfend age-
related ill health has become an international priority.10,11
The nexus of ‘phenotypic’ frailty involves loss of muscle
strength and mass, impaired locomotion, diminishing physical
function, and fatigue.1,4,12 Though complex, there is strong
evidence that these factors are modifiable, making them sa-
lient targets for preventing or postponing the adverse conse-
quences of frailty.1,4,5,13–15 However, devising pragmatic and
demonstrably effective interventions for this multifaceted
condition has proven challenging.15,16 Although numerous
studies have targeted various aspects of frailty or disability
in older people, particularly those relating to physical perfor-
mance, the results have been mixed, besides being difficult to
compare due to differing inclusion criteria, methodologies,
and operational definitions of frailty.14–19 Few studies have
recruited participants based on specific frailty criteria—fewer
still evaluated frailty itself as a primary outcome.14,15,20 Con-
sequently, it remains uncertain which approaches are most
likely to be effective and economically expedient,15,16,18,19 al-
though there is consensus that exercise training can prevent
or delay the onset of physical frailty.15,17,18 Emerging evi-
dence supports conjecture that multidomain interventions
that address complex individual care needs might be more
advantageous than those focused on specific diseases or def-
icits, but further research is needed to resolve current uncer-
tainties.1,15,16,19 There is a dearth of research on cognitive or
psychosocial factors, despite their probable role in bolstering
resilience in old age.4,15,17,18,21
To advance healthier aging on a global scale, interven-
tions to prevent frailty must be pragmatic, affordable,
and generalizable to different societal structures and cir-
cumstances. To this end, we developed two community-
based multidomain interventions, administered using sim-
ple resources, and evaluated their effect in preventing
physical and cognitive decline among senior citizens at
risk of adverse frailty-related outcomes. We emulated
contemporary trials of lifestyle interventions in older peo-
ple in using a cluster-randomized design,22–25 which is ex-
pedient and facilitates robust comparative analyses in
such settings. We observed significant improvements in
aspects of physical, cognitive, and functional performance
among elders who participated in both multidomain inter-
ventions and report new evidence that such interventions
were most effective among participants who were




Taiwan Health Promotion Intervention Study for Elders com-
prised complementary prospective cluster-randomized trials
(Supporting Information, Figure S1), conducted from 2014
to 2017: one assessed the efficacy of a 12 month participa-
tory community-group multidomain intervention against
physical and cognitive decline among prefrail/frail
community-dwelling older people (Efficacy Study); the other
evaluated the benefit of further empowering individual par-
ticipants (Empowerment Study). Trials designed to compare
interventions that entail group activities involving partici-
pants from single communities have inherent problems with
contamination and participant blinding. Therefore, we used
a cluster-randomized design, both to control for between-
group contamination and to facilitate evaluation of imple-
mentation effectiveness. Unlike conventional randomized
controlled trials, which compare intervention effects on indi-
vidual outcomes, cluster randomization allows powerful ex-
trapolation of the findings to the entire community (cluster)
studied.
The Efficacy Study enrolled participants from 40 clusters
(community centers/neighborhoods with 500–1000 resi-
dents ≥65 years old) in five cities/counties across Taiwan:
Taipei, Taichung, and Kaohsiung, Yilan, and Kinmen; the
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Empowerment Study enrolled a separate cohort of partici-
pants, who did not overlap with those in the Efficacy Study,
from another 14 clusters in Taipei, Taichung, and Kaohsiung
(Figure 1). From 12 February 2014 until 5 May 2016,
trained staff visited community centers to tell local
residents about the study and interviewed potential
participants to assess their eligibility. The inclusion
criteria were age ≥65 years; currently receiving Taiwan
National Health Insurance services; subjective memory
impairment and/or loss of ≥1 instrumental activities of
daily living (IADL), and/or timed 6 m walk speed ≤1
m/s; and competence to sign informed consent person-
ally and to comply with study procedures. Exclusion
criteria were age <65 years; dementia diagnosed accord-
ing to the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition26 or suspected by a clinician;
self/caregiver-reported total or partial dependence for
ADL, or major illness with life expectancy <6 months;
interviewer-adjudicated severe hearing or visual impair-
ment; documented major depression or anxiety, or other
major illness that may jeopardize compliance (at investi-
gators’ discretion); institutionalization; or current partici-
pation in other clinical studies or research. Independent
researchers not involved in assessing outcomes used a
random number sequence generated by Excel 2013
(Microsoft, Redmond, WA, USA) to allocate participants
in clusters, by simple direct sampling, 1:1 to intervention
or control groups. Opaque sealed envelopes were used
to conceal the interventions allocated from participants
and assessors.
Ethical compliance and trial registration
The Taiwan Health Promotion Intervention Study for Elders
was conducted according to the ethical standards established
by the 1964 Declaration of Helsinki and later amendments,
and prevailing national regulations and guidelines. The Joint
Institutional Review Board of Taiwan reviewed and approved
the trial protocols (JIRB No. 14-001-A). All study participants
provided written informed consent before any study-related
procedure ensued.
The Taiwan Health Promotion Intervention Study for Elders
was registered retrospectively, on 17 February 2017, at
ClinicalTrials.gov: NCT03056768.
Procedures
The Efficacy Study compared the effect of multidomain inter-
vention over 12 months with conventional health education,
and the Empowerment Study compared implementing the
same standard multidomain intervention as was used in the
Efficacy Study for 6 months, vs. an enhanced version of that
programme, with post-intervention follow-up at 9 months
(Supporting Information, Figure S1).
Figure 1 Efficacy and Empowerment Studies: participant selection, randomization, and disposition. ADL, activities of daily living.
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The multidomain interventions were administered by ap-
propriate professionals (e.g. fitness coach, physical therapist,
occupational therapist, and dietician) or by trained staff. Be-
fore either study commenced, an instructor manual was pro-
duced, and training workshops for all prospective instructors
were held to standardize implementation. Once trained, the
same instructor could conduct all major intervention activi-
ties. The manual specified the principal goals of each inter-
vention but gave instructors some flexibility in exactly how
to achieve these.
Efficacy study
Conventional health education in the Efficacy Study control
group entailed periodic telephone calls (~3 monthly) by local
research site staff to offer participants health education and
advice (the intervention group did not receive such calls).
The multidomain intervention was adapted from that used
in the Multidomain Alzheimer’s Preventive Trial (MAPT),27
which integrated physical exercise, cognitive training, and nu-
tritional counselling components that were straightforward
to organize in community settings and well accepted by
participants.
The Efficacy Study programme scheduled four structured
2 h training sessions in the first month, two during the sec-
ond, and one in each of the next 10 months (Supporting
Information, Figure S1); the first was held on 30 August
2014. To promote effective delivery, each cluster was
divided into smaller groups of five to eight people per
session, and research staff made reminder telephone calls
to local participants before each session to maximize
attendance. The routine curriculum comprised 45 min of
physical fitness activities, specifically aerobic exercises,
resistance work, and balance and flexibility training; 1 h
of cognitive training, including reasoning and memory
exercises; and 15 min of general nutrition advice, including
a balanced diet and adequate protein intake (Supporting
Information, Appendix S1). Participants were actively
encouraged to practice on their own at home. In addition,
every 3 or 4 months, some activities were curtailed, and a
visiting doctor instead gave a 30–60 min class on
preventing/managing chronic disease, which included
education about healthy aging, dementia, cardiovascular
risk factors, osteoporosis, and sarcopenia.
Empowerment study
The enhanced multidomain intervention programme in the
Empowerment Study replicated the format and schedule of
the first 6 months (10 sessions) of the Efficacy Study
(Supporting Information, Figure S1). However, the training
sessions used new teaching materials, revised and simplified
from the standard multidomain prototype, which addressed
feedback from a needs-assessment survey in local
communities. Participants were also given a pedometer and
post-curriculum learning sheets to support goal setting and
monitoring and additionally empowered by community
leader involvement, group competitions, and individual moti-
vation (Supporting Information, Appendix S1).
Assessments and outcomes
Baseline demographic and health-related data included par-
ticipants’ age, sex, race, tobacco smoking and alcohol con-
sumption behavior, and self-reported history of
hypertension, diabetes mellitus, cardiovascular disease,
stroke, and/or malignancy. Physical, cognitive, and functional
performance were assessed at baseline and 6 months in both
studies, with final follow-up at 12 months in the Efficacy
Study and at 9 months (3 months after the intervention
ceased) in the Empowerment Study. The last study assess-
ment was on 9 May 2017, and data were locked on 6 June
2017.
Physical measurements included time taken to walk 6 m at
normal walking pace, handgrip strength by dynamometry
(Smedlay’s Dynamo Meter, TTM, Tokyo, Japan), and physical
activity in units of metabolic equivalent of task (MET),28
based on a validated Leisure-Time Physical Activity question-
naire.29 Frailty was defined according to modified Cardiovas-
cular Health Study (CHS) criteria,12 comprising weak grip of
<26.0 kg in men or <18.0 kg in women; walking slower than
0.8 m/s; self-reported exhaustion on more than 3 days/week;
unintentional weight loss of >5.0 kg or 10% during the past
year; and physical activity <3.75 MET/h in men or <2.5
MET/h in women (lowest quintile of sex-specific baseline
values). People fulfilling three or more criteria were classed
as frail, those who met one or two as prefrail, and those with
no such deficits as robust.
General cognitive performance was evaluated using a ver-
sion of the Montreal Cognitive Assessment screening tool,
with cut-offs adjusted for Taiwanese Chinese users
(MoCAadj); one point was added to participants educated
for <12 years.30 The full MoCA battery covers most domains
affected by mild cognitive impairment, including visuospatial
executive, naming, concentration, language, abstract think-
ing, delayed recall, and orientation. Functional status was
based on established indicators—the five-item Geriatric De-
pression Scale (GDS-5),31 Mini-Nutritional Assessment short-
form (MNA-SF),32 and IADL.33
Primary and secondary outcomes
The primary outcomes were changes from baseline in CHS
frailty score, gait speed, grip strength, and MoCAadj. Second-
ary outcomes were IADL, nutrition status, and depressive
symptoms; MNA-SF ≤11 and/or GDS-5 ≥2 defined high risk
of being malnourished and/or depressed, respectively.
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Statistical analysis
All statistical analyses used SPSS Version 24.0 for Microsoft
Windows 7 (IBM Corp., Armonk, NY, USA). Sample size calcula-
tions were based on another investigation of the effect of nu-
tritional, cognitive, and physical interventions on frailty,14 in
which 1 year CHS frailty scores of 1.2 vs. 1.6 in intervention
and control groups, respectively, resulted in a Cohen’s d effect
size of 0.39.34 Assuming equal cluster sizes, constrained to 20
people on average, and an intra-cluster correlation coefficient
of 0.1, at least 16 clusters in the intervention and control
groups would be needed to achieve discriminatory power of
0.8 at the two-sided alpha level of 0.05; however, anticipating
a completion rate of around 70%,22–24 we aimed to include
≥20 clusters in each group. The analytic population samples in-
cluded all intervention participants with at least one post-
baseline observation (modified intention to treat). Missing
data were not imputed. A generalized linear mixed model,
which assumed data to be missing at random, was used to an-
alyze changes in outcome variables as functions of treatment
group, time, and Group × Time interaction, with random effect
applied at cluster level to account for participant clustering
within each community. These analyses were adjusted for sta-
tistically significant differences in baseline characteristics be-
tween intervention groups, except for significantly correlated
pairs of variables, in which case only one was adjusted to avoid
collinearity. Analyses were repeated for participants aged ≥75
years. Cohen’s d effect sizes were calculated from mean
changes derived from the generalized linear mixed model.
Results
Participant disposition and characteristics
Between 12 February 2014 and 5May 2016, 1907 people ≥65
years old from 54 community center/neighborhood clusters
across five regions of Taiwan were screened for participation
in two complementary studies; 1522 (79.8%), all
Chinese/Taiwanese, fulfilled eligibility criteria and consented
to enroll (Figure 1). The Efficacy Study assigned 19 clusters
(549 participants) to receive multidomain intervention and
21 clusters (533 participants) to conventional health educa-
tion. The median cluster size was 26. Participants in all 40
clusters received the treatment allocated, and more than
70% completed the study; 25.3% in the intervention group
and 29.6% in the control group discontinued or were lost to
follow-up (Figure 1A). The Empowerment Study separately
enrolled another 440 participants, and randomized seven
clusters (210 participants) to receive the standard
multidomain intervention used in the Efficacy Study, and
seven clusters (230 participants) to receive the adapted ver-
sion of the standard prototype, enhanced to empower
participants. The median cluster size in the Empowerment
Study was 33, and the completion rate was ~90% (Figure 1B).
Both randomization groups in either study had broadly sim-
ilar baseline characteristics (Table 1). Participants were pre-
dominantly women, with average age ≥75 years, and were
evenly distributed between rural and urban residents. Half
of both study cohorts had high blood pressure, and 20–25%
had diabetes or cardiovascular disease. Frailty status and
other physical assessments were mostly similar between
groups; however, some differences in baseline cognitive per-
formance and IADL were statistically significant. Efficacy Study
multidomain intervention recipients had better overall cogni-
tive, visuospatial executive, and language performance vs.
controls and higher mean IADL (all P < 0.05). Empowerment
Study participants in the enhanced multidomain intervention
group performed worse than controls in cognitive domains
of naming, concentration, and abstract thinking (all P< 0.05).
Intervention outcomes
Efficacy study: standard multidomain intervention
Although participants in the Efficacy Study multidomain inter-
vention had lower CHS frailty scores at interim and final
follow-up than at baseline and compared with controls
(Figure 2A; Supporting Information, Table S1), neither differ-
ence was statistically significant. The multidomain interven-
tion did not significantly improve other overall physical or
functional outcomes by 6 months, but concentration im-
proved significantly (Figures 2A–2C, 3A, and 4A; Supporting
Information, Tables S1 and S2). At 12 months, intervention
group participants were half as likely than controls to have
depressed mood [odds ratio 0.56, 95% confidence interval
(CI) 0.32, 0.99, P = 0.044] or malnutrition (odds ratio 0.45,
95% CI 0.26, 0.78, P = 0.004); continued gains in concentra-
tion contributed to a rising trend in overall cognitive perfor-
mance (MoCAadj 1.03, 95% CI 0.19, 2.24, P = 0.094)
(Figures 2B and 2C and 4A; Supporting Information, Tables
S1 and S2).
Empowerment study: enhanced multidomain intervention
The results of enhanced vs. standard multidomain interven-
tion in the Empowerment Study had commonalities with
the intervention effects observed in the Efficacy Study,
but with significantly improved gait speed and physical ac-
tivity at 6 months, and even lower prevalence of malnutri-
tion (odds ratio 0.39, 95% CI 0.18, 0.84, P = 0.016) and
enhanced delayed recall and overall cognitive performance
at 9 months (Figures 2A–2C, 3B, and 4B; Supporting Infor-
mation, Tables S1 and S2). Unlike the Efficacy Study, de-
pressed mood did not differ significantly between the
intervention and control groups (Figure 2B; Supporting In-
formation, Table S1).
654 L.-K. Chen et al.
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≥75-year-olds
The prevalence of frailty was higher among study participants
aged ≥75 years compared with the entire population: 10.5%
vs. 7.6% overall; 9.2% vs. 7.5% in the Efficacy Study; and
13.3% vs. 7.8% in the Empowerment Study. Efficacy Study
participants ≥75 years old had some more pronounced
improvements relative to controls than those observed over-
all, including significantly lower CHS frailty scores at both 6
and 12 months, stronger grip at 6 months, and lower GDS-5
score and enhanced delayed recall and overall cognition at
12 months (Supporting Information, Tables S1 and S2 and
Figures S2, S3, and S4); ≥75-year-olds in the Empowerment
Figure 2 Mean changes from baseline performance. (A) Physical domains; (B) functional domains; and (C) cognitive domains. CHS, Cardiovascular







P < 0.001; vertical bars indicate standard error.
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Study had a significantly lower frailty score and less prevalent
frailty at 6 months and more pronounced differences in phys-
ical activity and IADL at both 6 and 9 months. Both the stan-
dard and enhanced multidomain interventions significantly
improved cognitive performance among ≥75-year-olds, with
a sustained gain 3 months after the participant-empowered
intervention ceased similar to that seen in the overall popula-
tion (Supporting Information, Tables S1 and S2 and Figures
S2, S3, and S4).
Estimated magnitude of intervention effects
Estimated effect sizes in direct comparisons between each
intervention and its control at 6 and 12 months (Efficacy
Study) or 9 months (Empowerment Study) were congruent
with the significant interactions identified in linear mixed
model analyses (Supporting Information, Table S3). Cohen’s
d coefficients indicated small positive effects on CHS frailty
score, physical activity, delayed recall, and IADL at 6 months
in the Empowerment Study and on concentration at 12
months in the Efficacy Study. Similar effect sizes on overall
cognitive performance, delayed recall, IADL, and malnutri-
tion were evident at the 9 month follow-up in the Empower-
ment Study. Because each study involved different
participants, it was not possible to estimate the effect of en-
hanced multidomain intervention relative to conventional
health education directly; however, indirect comparison indi-
cated small/medium overall effects on CHS frailty score, gait
speed, physical activity, delayed recall, and IADL at 6 months
and on cognitive performance, IADL, and depression at
study end, with stronger effects on delayed recall and
malnutrition.
Figure 3 Intervention effects on physical and functional performance. (A) Efficacy Study; (B) Empowerment Study. CHS, Cardiovascular Health Study;
MET, metabolic equivalent of task. Horizontal bars indicate 95% confidence intervals at 6 months (blue) and 12 or 9 months (orange).
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Discussion
The Taiwan Health Promotion Intervention Study for Elders
has produced further evidence that pragmatic multidomain
interventions may simultaneously help to reverse both phys-
ical and cognitive decline among vulnerable older people. Im-
portantly, an enhanced programme that empowered and
motivated participants produced more pronounced benefits,
and this is the first study showing that participants ≥75 years
old had even greater improvements in their physical and
mental performance than younger ones, including
significantly diminished prevalence of frailty during the inter-
vention. The interventions were straightforward to imple-
ment in the community setting by trained personnel. These
results support a rationale for universal implementation of
community-based programmes to promote healthy aging
and reduce late-life disability and cognitive decline, and have
important implications for preparatory policy planning.
The standard multidomain intervention in our Efficacy
Study resulted in improvements across core components of
phenotypic frailty, particularly in physical (grip strength) and
functional (depression and malnutrition) domains, with
Figure 4 Intervention effects on cognitive performance. (A) Efficacy Study; (B) Empowerment Study. Horizontal bars indicate 95% confidence intervals
at 6 months (blue) and 12 or 9 months (orange).
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consequently reduced CHS frailty scores. Significantly im-
proved IADL among ≥75-year-olds both during and after the
enhanced multidomain intervention, with a less pronounced
effect in the Efficacy Study, suggests that reinforcing lifestyle
behavior changes could potentially pre-empt, even reverse,
disability. Malnutrition is another important determinant of
frailty and late-life cognitive decline,21 and both multidomain
interventions had significantly lessened the prevalence of
malnutrition at final follow-up.
The improvement in physical activity in the Efficacy Study
was greater over 0–6 months than 0–12 months, which
may imply that decreased intervention frequency
attenuated the effect; on the other hand, improvements
in cognition, depressed mood, and malnutrition were
greater after 12 months than at 6 months. Likewise, gains
in gait speed and physical activity plateaued from 6
months, after the Empowerment Study intervention ended,
whereas improvements in nutrition status and cognition
were sustained at the 9 month post-intervention
follow-up. Later-onset improvements in cognitive
performance and nutrition status after the intervention
intensity dropped to once-monthly maintenance session,
or ceased in the Empowerment Study, suggest that a prag-
matic community-based programme could yield sustainable
benefits. Pertinently, a less onerous intervention schedule
would be more amenable to national-scale implementation.
Further studies are warranted to determine for how long
the legacy effect of participant empowerment persists, and
to follow-up longer-term outcomes such as quality of life,
which may be a more appropriate indicator of healthy aging,
or even mortality.
These findings reinforce strong evidence that interven-
tions that incorporate exercise training, either with or
without nutrition, are effective in reversing frailty and phys-
ical disability, with some sustained gains.14,15,20,35–39 In
contrast, several geriatric care models that implemented
individual needs assessment and tailored multidisciplinary
management have shown little or no benefit compared
with usual primary care.15,22–25 Disparity between the
results of participatory vs. service-based approaches may
reflect the importance of the psychosocial context in
interventions that improve well-being, which has been
underappreciated.15,18
In long-running controversy about how best to define
and operationalize the elusive concept of frailty, propo-
nents of cumulative deficit models, which integrate cogni-
tive and psychosocial dimensions among others, have
criticized ‘biological’ frailty as narrow and simplistic.4,21
However, phenotypic criteria are practical to apply, and
fewer intervention studies have employed multidimensional
definitions of frailty.15,21 A notable feature of successful
interventions such as ours is that they provide participants
with opportunities for social inclusion and mental
stimulation, such as group exercise, cognitive training, or
psychological support.14,20,35,37 Even better results may be
obtained by engaging, empowering, and motivating
participants, for example, by goal setting.37,40 In the
Empowerment Study, such enhancements consolidated
gains in physical activity, improved nutrition status, and
overall cognition; the remarkable 90% completion rate indi-
cates an unusually high level of participant satisfaction and
may also be attributed to the peer effect in a
cluster-randomized study design. Although the effect sizes
we detected were small/medium at best, small long-term
effects can nonetheless be highly consequential in a public
health context.41 Furthermore, indirect comparison of the
Efficacy and Empowerment Studies suggested an additive
effect of enhanced multidomain intervention, possibly
reflecting functional interrelationships between physical
activity, cognition, and frailty.
Physical exercise probably has psychological benefits, and
cognitive training, vice versa, appears to improve aspects of
physical function such as balance and gait speed, although
the mechanisms remain obscure.14,16 Despite evidence that
cognitive reserve may support coping in older age and that
cognitive deficits or mood disturbances may be other mani-
festations of frailty,4,21 few studies have evaluated cognitive
or mental health outcomes.15 A multidomain intervention
targeting vascular risk factors for dementia had no effect on
cognition or depressive symptoms, nor in preventing demen-
tia.24 In the Lifestyle Interventions and Independence for El-
ders study, a 2 year programme of moderate-intensity
physical exercise did not improve cognitive functioning, but
neither did it decline.42 However, a multidomain intervention
that included diet, exercise, and cognitive training, as well as
fostering social activities, reduced the risk of cognitive decline
in at-risk older people.41 In an ancillary MAPT subgroup
study, intervention with omega-3 supplementation and/or
physical activities, cognitive exercises and nutritional advice,
improved cognitive performance compared with placebo
among elderly people at risk for developing dementia who
had positive amyloid status.43 The MAPT multidomain inter-
vention was also associated with reduced risk of incident
frailty in a secondary analysis.44 In Singapore, cognitive train-
ing focused on short-term memory, attention, information
processing and reasoning, reduced frailty, and improved
lower limb strength.14 Our standard multidomain interven-
tion significantly improved concentration, which, combined
with delayed recall, contributed to enhancing overall cogni-
tive performance among ≥75-year-olds; borderline improve-
ment of MoCAadj at 12 months in the whole Efficacy Study
cohort was possibly due to insufficient follow-up. The
multidomain intervention also significantly reduced the prev-
alence of depressed mood. The enhanced multidomain inter-
vention did significantly improve overall cognition, despite a
non-significant between-group effect on concentration,
driven by significantly improved delayed recall relative to
the standard multidomain intervention.
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Frailty interventions have been shown to be effective at
ages from 65 years upward, but the potential effect of partic-
ipant’s age on their impact is little studied. Among four re-
ports,15 only one found age to be a moderating factor, with
younger subjects more likely to revert from frail to robust sta-
tus.45 In both of our studies, ≥75-year-olds, who had higher
prevalence of frailty, appeared to have some more pro-
nounced and sustained improvements in domains of physical
performance (CHS frailty score and handgrip strength), func-
tioning (IADL), and overall cognition (MoCAadj) than younger
participants. This novel finding suggests that people at poten-
tially higher risk for adverse consequences of frailty may ben-
efit most from such intervention, in which case healthy aging
initiatives that focus on the older elderly may be particularly
expedient.
The Taiwan Health Promotion Intervention Study for
Elders used a rigorous, evidence-based, cluster-randomized
design to produce data commensurate with those of other
randomized controlled trials and thereby contribute to
efforts to ascertain the most effective approaches to
preventing or treating frailty, which is urgent given its
increasing socio-economic impact.19 Although cluster-
randomized trials are relatively scarce compared with
typical randomized designs, perhaps due to being hard to
conduct in real-world settings, this powerful approach is
increasingly common in modern pragmatic trials. We
recruited a nationally representative sample of
prefrail/frail individuals from rural and urban areas through-
out Taiwan; broadly similar baseline characteristics between
intervention arms indicate that cluster randomization did
not introduce significant bias and that the impact of
unmeasured confounders may have been minimized.
Another strength of these studies was extraordinarily high
retention rates, especially in empowered participants,
which highlights the value of considering the characteristics
and needs of potential participants when designing
community-based intervention programs. However, this
may also reflect unique local circumstances, as noted in
another study of ethnically Chinese older adults, and not
necessarily extrapolate to all prefrail populations.14
Cost-effectiveness will be a key consideration in incorporat-
ing such interventions into healthy aging strategies, and in
this regard, participatory communal programs may provide
better value for money than individualized treatment,
especially for very frail individuals.15,37 Our study provides
a rare and powerful example of a practical and sustainable
community-based intervention that can be implemented
using simple materials and existing facilities. Although the
Taiwan Health Promotion Intervention Study for Elders
was not intended to evaluate cost-effectiveness, the inter-
ventions were designed to be affordable, in not necessarily
requiring any specialist medical equipment or facilities.
Notwithstanding these strengths, we acknowledge sev-
eral limitations. (i) Participant blinding was difficult to
achieve in the Efficacy Study, due to the evident difference
in the interventions compared, but this issue is inherent to
behavior-based studies. (ii) The Empowerment Study, with
only seven clusters per arm, was probably underpowered.
(iii) The study design precluded direct comparison of the
effect of participant-empowered multidomain intervention
vs. conventional health education, or evaluation of the
contribution of individual multidomain components to
reducing frailty; however, the exigent knowledge gap
is not whether, but which, multidomain intervention is
better.
Overall, our results affirm that an integrated multidomain
intervention programme, including physical exercise, cogni-
tive training, nutrition advice, and disease education, can pre-
vent or reverse frailty by improving principal determinants of
physical well-being and mental health among prefrail/frail
community-dwelling older people, especially among people
older than 75. The standardized protocol used in this study
is amenable to inclusion in policies to promote healthy aging
and may supplement them more effectively and sustainably,
if implemented via strategies that motivate and empower
participants.
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